Trends & Insights: March 2026 – A pharmaphorum industry report

Trends & Insights: March 2026 – A pharmaphorum industry report

Byadmin

From chip giant NVIDIA agreeing a $2 billion partnership with AI cloud provider Nebius, to Roche ramping up its investment in NVIDIA’s AI chips, and a hacking group claiming to have broken into AstraZeneca’s IT systems; from a patient advocacy group in the UK calling for changes to the decade-old meningitis vaccination programme, after an…

Trends & Insights, January 2026: A pharmaphorum industry report

Trends & Insights, January 2026: A pharmaphorum industry report

Byadmin

Outside of what we’ve been reporting on in terms of news and in-depth features, interviews, and in-person event coverage, behind the headlines the year also opened with a flurry of regulatory milestones, ophthalmology advances, AI-first R&D announcements, and tangible investments in manufacturing and packaging capacity. Amid this, oncology continued to dominate outcomes news, but two…